Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on April 4, 2025
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
GlobeNewswire
·
April 4, 2025
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capacity of …
Best Cutting and Bulking Steroids - Buy Oral Steroid Stacks for Muscle Gain, Fat Loss and Strength from CrazyBulk
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Using steroids for bodybuilding is typically divided into two distinct phases: the bulking phase and the cutting phase. Each phase has specific goals—bulking focuses on gaining muscle mass and strength, while …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …
Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation
GlobeNewswire
·
April 4, 2025
– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation in healthy volunteers – – Findings support continued …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
RESEARCH TRIANGLE PARK, N.C., April 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees restricted stock units (RSUs) …
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
GlobeNewswire
·
April 4, 2025
LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature …
NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 4, 2025
BELTSVILLE, Md., April 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it …
Axsome Therapeutics Presents Positive Pivotal Phase 3 Results of the ACCORD-2 Trial of AXS-05 in Alzheimer’s Disease Agitation and the SYMPHONY Trial of AXS-12 in Narcolepsy at the 2025 American Academy of Neurology (AAN) Annual Meeting
GlobeNewswire
·
April 4, 2025
Late-breaking oral presentation of results from the positive pivotal ACCORD-2 Phase 3 trial of AXS-05 in Alzheimer’s disease agitation Presentation featuring network meta-analysis of SYMBRAVO® versus oral CGRPs NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- …
サイ・ライフ・サイエンシズ (Sai Life Sciences)、インドにペプチド研究センターを設立
GlobeNewswire
·
April 4, 2025
インド・ハイデラバード発, April 04, 2025 (GLOBE NEWSWIRE) -- イノベーター志向の医薬品受託研究開発製造機関 (CRDMO) であるサイ・ライフ・サイエンシズ・リミテッド (Sai Life Sciences Limited)(BSE: 544306 I NSE: SAILIFE) は、このたびインド・ハイデラバードにある統合型研究開発キャンパス内に、専用のペプチド研究センターを開設した。 この開設にあたり、サイ・ライフ・サイエンシズ CEO …
Verano to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 4, 2025
CHICAGO, April 04, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the first quarter ended …
New LabTAG Add-On Streamlines Laboratory Labeling with Dymo® LabelWriter™ 5-Series and eLabNext Integration
GlobeNewswire
·
April 4, 2025
BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- GA International, a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its DYMO® LabelWriter™ 5-Series Printing Kits are now compatible with eLabNext’s Digital Lab …